Federated Hermes, Inc. Lexicon Pharmaceuticals, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 6 shares of LXRX stock, worth $4. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 1 500.0%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.51 - $2.39 $7 - $11	5 Added 500.0%	6 $0
Q2 2024 Aug 08, 2024	BUY	$1.54 - $2.28 $1 - $2	1 New	1 $0
Q3 2023 Nov 13, 2023	BUY	$1.06 - $2.33 $7,340 - $16,135	6,925 Added 72.38%	16,493 $17,000
Q2 2023 Aug 14, 2023	BUY	$2.15 - $3.49 $20,571 - $33,392	9,568 New	9,568 $21,000
Q3 2021 Nov 15, 2021	SELL	$3.38 - $5.35 $72,686 - $115,051	-21,505 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.12 - $5.87 $8,581 - $12,227	2,083 Added 10.72%	21,505 $99,000
Q1 2021 May 13, 2021	SELL	$3.45 - $9.09 $39,840 - $104,971	-11,548 Reduced 37.29%	19,422 $114,000
Q4 2020 Feb 12, 2021	SELL	$1.05 - $3.67 $1.76 Million - $6.16 Million	-1,678,806 Reduced 98.19%	30,970 $106,000
Q2 2020 Aug 13, 2020	BUY	$1.75 - $2.3 $1.74 Million - $2.28 Million	992,069 Added 138.23%	1,709,776 $3.41 Million
Q1 2020 May 13, 2020	BUY	$1.8 - $4.28 $1.09 Million - $2.59 Million	605,310 Added 538.55%	717,707 $1.4 Million
Q4 2019 Feb 14, 2020	BUY	$3.16 - $5.15 $354,950 - $578,478	112,326 Added 158205.62%	112,397 $466,000
Q3 2019 Nov 14, 2019	SELL	$1.2 - $6.66 $11,749 - $65,208	-9,791 Reduced 99.28%	71 $1,000
Q2 2019 Aug 14, 2019	SELL	$5.35 - $7.11 $14,707 - $19,545	-2,749 Reduced 21.8%	9,862 $62,000
Q1 2019 May 10, 2019	BUY	$4.36 - $7.94 $51,103 - $93,064	11,721 Added 1316.97%	12,611 $70,000
Q4 2018 Feb 13, 2019	BUY	$6.15 - $10.51 $5,473 - $9,353	890 New	890 $5,000

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Lexicon Pharmaceuticals, Inc. Transaction History